These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 22934546)

  • 1. Review of evidence that epidemics of type 1 diabetes and type 2 diabetes/metabolic syndrome are polar opposite responses to iatrogenic inflammation.
    Classen JB
    Curr Diabetes Rev; 2012 Nov; 8(6):413-8. PubMed ID: 22934546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian pediatric data support hypothesis that simultaneous epidemics of type 1 diabetes and type 2 diabetes/metabolic syndrome/obesity are polar opposite responses (i.e., symptoms) to a primary inflammatory condition.
    Classen JB
    J Pediatr Endocrinol Metab; 2011; 24(7-8):455-6. PubMed ID: 21932581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic risk factors and mechanisms of disease in epithelial ovarian cancer: A review.
    Craig ER; Londoño AI; Norian LA; Arend RC
    Gynecol Oncol; 2016 Dec; 143(3):674-683. PubMed ID: 27751590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents.
    Syrenicz A; Garanty-Bogacka B; Syrenicz M; Gebala A; Walczak M
    Neuro Endocrinol Lett; 2006 Aug; 27(4):453-8. PubMed ID: 16892000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver.
    Sung KC; Lee MY; Kim YH; Huh JH; Kim JY; Wild SH; Byrne CD
    Atherosclerosis; 2018 Aug; 275():50-57. PubMed ID: 29860108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic factors and microinflammatory state promote kidney injury in type 2 diabetes mellitus patients.
    Cao C; Wan X; Chen Y; Wu W
    Ren Fail; 2009; 31(6):470-4. PubMed ID: 19839824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders.
    Pradhan A
    Nutr Rev; 2007 Dec; 65(12 Pt 2):S152-6. PubMed ID: 18240540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome-associated osteoarthritis.
    Courties A; Sellam J; Berenbaum F
    Curr Opin Rheumatol; 2017 Mar; 29(2):214-222. PubMed ID: 28072592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor- α and interleukin-6: potential interorgan inflammatory mediators contributing to destructive periodontal disease in obesity or metabolic syndrome.
    Khosravi R; Ka K; Huang T; Khalili S; Nguyen BH; Nicolau B; Tran SD
    Mediators Inflamm; 2013; 2013():728987. PubMed ID: 24068858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic processing in cardiometabolic disease.
    Costantino S; Mohammed SA; Ambrosini S; Paneni F
    Atherosclerosis; 2019 Feb; 281():150-158. PubMed ID: 30290963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive and maladaptive cortisol responses to pediatric obesity.
    Soros A; Zadik Z; Chalew S
    Med Hypotheses; 2008 Sep; 71(3):394-8. PubMed ID: 18547740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune responses and inflammation in type 2 diabetes.
    Prasad M; Chen EW; Toh SA; Gascoigne NRJ
    J Leukoc Biol; 2020 May; 107(5):739-748. PubMed ID: 32202348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges.
    Pannu S; Rosmarin D
    Am J Clin Dermatol; 2021 May; 22(3):293-300. PubMed ID: 33586126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and oxidative stress in obesity, metabolic syndrome, and diabetes.
    Galassetti P
    Exp Diabetes Res; 2012; 2012():943706. PubMed ID: 23319940
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic syndrome in Children: An emerging Epidemic.
    Ishaque A
    J Pak Med Assoc; 2021 Feb; 71(2(A)):396. PubMed ID: 33819213
    [No Abstract]   [Full Text] [Related]  

  • 16. Cortisol: the villain in metabolic syndrome?
    Paredes S; Ribeiro L
    Rev Assoc Med Bras (1992); 2014; 60(1):84-92. PubMed ID: 24918858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Type 1 and type 2 diabetes mellitus in Germany. An epidemic in all age groups].
    Danne T
    MMW Fortschr Med; 2004 May; 146(20):27. PubMed ID: 15344728
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of Positive Diabetes-Associated Autoantibodies among Type 2 Diabetes and Related Metabolic and Inflammatory Differences in a Sample of the Bulgarian Population.
    Zaharieva ET; Velikova TV; Tsakova AD; Kamenov ZA
    J Diabetes Res; 2017; 2017():9016148. PubMed ID: 28573146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Obesity in children and adolescents and diabetes].
    Nazim J; Starzyk J
    Przegl Lek; 2009; 66(1-2):96-9. PubMed ID: 19485265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in Japanese children.
    Kitagawa T; Owada M; Urakami T; Tajima N
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S7-13. PubMed ID: 7859637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.